ORIGINAL RESEARCH ARTICLES
1219 -- Does Therapeutic Use of Acetaminophen Cause Acute Liver Failure?
Richard C. Dart, M.D., Ph.D., and Elise Bailey, M.S.P.H.
1231 -- Comparison of the Dose Response to Levalbuterol with and without Pretreatment with S-Albuterol After Methacholine-Induced Bronchoconstriction
Hengameh H. Raissy, Pharm.D., Michelle Harkins, M.D., Anna Esparham, B.S., and H. William Kelly, Pharm.D.
1237 -- Risk of Warfarin-Related Bleeding Events and Supratherapeutic International Normalized Ratios Associated with Complementary and Alternative Medicine: A Longitudinal Analysis
Stephen Shalansky, Pharm.D., FCSHP, Larry Lynd, B.S.P., Ph.D., Kathryn Richardson, M.Sc., Andrew Ingaszewski, M.D., FRCPC, and Charles Kerr, M.D., FRCPC
1248 -- T-Cell Responses to Hepatitis B Surface Antigen in Lung Transplant Recipients
Mary S. Hayney, Pharm.D., Nicholas A. Wiegert, B.S., Frances L. Pelsue, B.S., Renee M. Fohl, B.S., Ewa Jankowska-Gan, M.S., Robert B. Love, M.D., and William J. Burlingham, Ph.D.
1253 -- Pharmacokinetics of a Guanfacine Extended-Release Formulation in Children and Adolescents with Attention-Deficit-Hyperactivity Disorder
Samuel W. Boellner, M.D., Michael Pennick, B.Sc., Kimberly Fiske, B.S., Andrew Lyne, M.Sc., and Amir Shojaei, Ph.D.
RESEARCH REPORTS
1263 -- Enoxaparin Use in the Neonatal Intensive Care Unit: Experience Over 8 Years
Janet I. Malowany, B.H.Sc.(Hons), David C. Knoppert, M.Sc.Phm., FCCP, M.Sc., Anthony K. C. Chan, M.B.B.S., FRCPC, Dion Pepelassis, M.D., and David S. C. Lee, M.B.B.S., FRCPC
1272 -- Lack of an Effect of Oral Iron Administration on Mycophenolic Acid Pharmacokinetics in Stable Renal Transplant Recipients
Daniele K. Gelone, Pharm.D., Jeong M. Park, M.S., Pharm.D., and Kathleen D. Lake, Pharm.D.
REVIEW OF THERAPEUTICS
1279 -- Potential Roles for Statins in Critically Ill Patients
Kyle A. Weant, Pharm.D., and Aaron M. Cook, Pharm.D.
MINIREVIEWS
1297 -- Monotherapy versus Combination Therapy with Class III Antiarrhythmic Agents to Attenuate Transmural Dispersion of Repolarization: A Potential Risk Factor for Torsade de Pointes
Sachin A. Shah, Pharm.D., Jeffrey Kluger, M.D., and C. Michael White, Pharm.D.
1306 -- The Utility of Hospital Antibiograms as Tools for Guiding Empiric Therapy and Tracking Resistance: Insights from the Society of Infectious Diseases Pharmacists
Amy L. Pakyz, Pharm.D., M.S.
1313 -- Interference of Maltose, Icodextrin, Galactose, or Xylose with Some Blood Glucose Monitoring Systems
Thomas G. Schleis, M.S.
PRACTICE INSIGHTS
1322 -- Discordant Effects of b-Blockade on Central Aortic Systolic and Brachial Systolic Blood Pressure: Considerations Beyond the Cuff
Benjamin J. Epstein, Pharm.D., and Shawn Anderson, Pharm.D.
CASE REPORTS
1334 -- Safe Use of Meropenem in a Patient with a Possible Nonimmediate Allergy to Imipenem
Karim Lakhal, M.D., Brice Lortat-Jacob, M.D., Catherine Neukirch, M.D., Olivier Pajot, M.D., and Michel Wolff, M.D.
1339 -- Agitation Associated with Aripiprazole Initiation
Jessica W. Lea, Pharm.D., Steven C. Stoner, Pharm.D., and Jeremy LaFollette, Pharm.D.
1343 -- Clindamycin-Induced Sweet's Syndrome
Brychan M. Clark, M.D., Diane C. Homeyer, M.D., Kristen R. Glass, M.D., and Laurie C. D'Avignon, M.D.